Song (22-8-1 MMA, 11-3-1 UFC) returns to the cage in the co-main event of UFC 324 (Paramount+) Saturday at T-Mobile Arena in ...

If you're in the market for a comfortable yet stylish gaming chair that won't break your budget, then check out Andaseat's ...

Before you plug another banger into the sound system, follow these rules for playing bar songs on the jukebox so staff and ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

So there was no official song of summer. So let’s move beyond the biggest hits and check out the 10 songs we kept coming back to this year. The singer-songwriter who has worked with Miley Cyrus, ...

In 2019 I wrote about research suggesting anti-inflammatory medications might help some people with major depression. At the time, the idea that depression could have roots in the immune system felt ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, scientists preserved cognition in mice without dulling the cancer-killing ...

After nearly two hours of chatting, Izzy Hagerup throws her hands up in the air and admits, "I'm just really scared of music right now." Her eyes widen below her short-trimmed brown bangs. A smile ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...

The story of Q32 Bio, a company that develops therapeutics for inflammatory and autoimmune diseases, started two decades ago. That's when V. Michael Holers, MD, a University of Colorado School of ...